Join the club for FREE to access the whole archive and other member benefits.

Jon Rees

CEO and co-founder at MitoRx Therapeutics

Jon Rees is the CEO and co-founder at MitoRx Therapeutics. He has 16 years of working experience in industry including business development for Takeda Pharma Rare Diseases, VC deal sourcing for LSP.vc, successfully advising Ducentis BioTherapeutics on fundraising. Tranformative decade as spin-out CEO of leading biotech network OBN/BioTrinity. PKD patient charity trustee.

Jon completed his post-doc at the University of Oxford, PhD from the Royal Holloway University of London, a Masters with Distinction from LJMU and a BSc from University of Manchester Institute for Science and Technology.

Visit website: https://www.mitorxtherapeutics.com/#Our-team#JonRees

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

See also: Company MitoRx Therapeutics - Pre-clinical stage rare disease biotech company aiming to develop treatments for degenerative diseases

Jon Rees News

New longevity startup MitoRx Therapeutics is developing mitochondria protective drugs

Longevity Technology - 25-Apr-2022

Targeting age-related diseases, the company's pre-clinical compounds to progress to the clinic

Read more...